InvestorsObserver is giving Ginkgo Bioworks Holdings Inc (DNA) an Analyst Rating Rank of 20, meaning DNA is ranked higher by analysts than 20% of stocks. The average price target for DNA is $5.514 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating DNA a Buy today. Find out what this means to you and get the rest of the rankings on DNA!